Cargando…

A new screening method for ATP-independent kinase inhibitors identifies repurposed anti-cancer drugs()

Detalles Bibliográficos
Autores principales:	Timaner, Michael, Shaked, Yuval
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2018
Materias:	Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6286637/ https://www.ncbi.nlm.nih.gov/pubmed/30509398 http://dx.doi.org/10.1016/j.ebiom.2018.10.020

Ejemplares similares

Computational Screening Strategy for Drug Repurposing Identified Niclosamide as Inhibitor of Vascular Calcification
por: Tanaka, Takeshi, et al.
Publicado: (2022)

Repurposing an HIV Drug for Zika Virus Therapy
por: Xie, Xuping, et al.
Publicado: (2019)

High-throughput screen of drug repurposing library identifies inhibitors of Sarcocystis neurona growth
por: Bowden, Gregory D., et al.
Publicado: (2018)

Potential repurposing of oncology drugs for the treatment of Alzheimer's disease
por: Araki, Wataru
Publicado: (2013)

DRUG REPURPOSING—Overcoming the translational hurdles to clinical use
por: Martin, Jennifer H., et al.
Publicado: (2019)

Plitidepsin: a Repurposed Drug for the Treatment of COVID-19
por: Martinez, Miguel Angel
Publicado: (2021)

Repurposing Screens of FDA-Approved Drugs Identify 29 Inhibitors of SARS-CoV-2
por: Ku, Keun Bon, et al.
Publicado: (2020)

Repurposed drugs for COVID-19: threshold and proof requirements for trials
por: Paul, Mical, et al.
Publicado: (2021)

Systematic Repurposing Screening in Xenograft Models Identifies Approved Drugs with Novel Anti-Cancer Activity
por: Roix, Jeffrey J., et al.
Publicado: (2014)

To ATP or Not To ATP: This Is the Question
por: Accardi, Alessio
Publicado: (2008)

Drug Repurposing and De Novo Drug Discovery of Protein Kinase Inhibitors as New Drugs against Schistosomiasis
por: Pereira Moreira, Bernardo, et al.
Publicado: (2022)

Buying time: Drug repurposing to treat the host in COVID‐19H
por: Martin, Jennifer H., et al.
Publicado: (2020)

Informatics-guided drug repurposing for Autosomal Dominant Polycystic Kidney Disease (ADPKD)
por: Kiseleva, Anna A., et al.
Publicado: (2020)

New opportunities for kinase drug repurposing and target discovery
por: Knapp, Stefan
Publicado: (2018)

Excessive concentrations of kinase inhibitors in translational studies impede effective drug repurposing
por: Liu, Chuan, et al.
Publicado: (2023)

Repurposed drug screen identifies cardiac glycosides as inhibitors of TGF-β-induced cancer-associated fibroblast differentiation
por: Coleman, David T., et al.
Publicado: (2016)

Drug Repurposing Screening Identifies Tioconazole as an ATG4 Inhibitor that Suppresses Autophagy and Sensitizes Cancer Cells to Chemotherapy
por: Liu, Pei-Feng, et al.
Publicado: (2018)

Repurposing existing drugs for monkeypox: applications of virtual screening methods
por: Li, Vladimir, et al.
Publicado: (2023)

Can an FDA-Approved Alzheimer’s Drug Be Repurposed for Alleviating Neuronal Symptoms of Zika Virus?
por: Sirohi, Devika, et al.
Publicado: (2017)

Towards the network-based prediction of repurposed drugs using patient-specific metabolic models
por: Pacheco, Maria Pires, et al.
Publicado: (2019)

Repurposing of Kinase Inhibitors for Treatment of COVID-19
por: Weisberg, Ellen, et al.
Publicado: (2020)

Repurposing the Kinase Inhibitor Mavelertinib for Giardiasis Therapy
por: Michaels, Samantha A., et al.
Publicado: (2022)

Computationally-guided drug repurposing enables the discovery of kinase targets and inhibitors as new schistosomicidal agents
por: Giuliani, Sandra, et al.
Publicado: (2018)

iPSC screening for drug repurposing identifies anti‐RNA virus agents modulating host cell susceptibility
por: Imamura, Keiko, et al.
Publicado: (2021)

Drug repurposing screens identify chemical entities for the development of COVID-19 interventions
por: Bakowski, Malina A., et al.
Publicado: (2021)

Dose- and time-dependence of the host-mediated response to paclitaxel therapy: a mathematical modeling approach
por: Benguigui, Madeleine, et al.
Publicado: (2017)

Repurposing biomedical informaticians for COVID-19
por: Sosa, Daniel N., et al.
Publicado: (2021)

Repurposing Belinostat for Alleviation of Atopic Dermatitis
por: Quah, Shan, et al.
Publicado: (2021)

High-throughput screening identified selective inhibitors of exosome biogenesis and secretion: A drug repurposing strategy for advanced cancer
por: Datta, Amrita, et al.
Publicado: (2018)

Identifying SARS-CoV-2 Entry Inhibitors through Drug Repurposing Screens of SARS-S and MERS-S Pseudotyped Particles
por: Chen, Catherine Z., et al.
Publicado: (2020)

A drug repurposing screen identifies hepatitis C antivirals as inhibitors of the SARS-CoV2 main protease
por: Baker, Jeremy D., et al.
Publicado: (2021)

Identifying FAAH Inhibitors as New Therapeutic Options for the Treatment of Chronic Pain through Drug Repurposing
por: Zanfirescu, Anca, et al.
Publicado: (2021)

Unlocking potential inhibitors for Bruton's tyrosine kinase through in-silico drug repurposing strategies
por: Alrouji, Mohammed, et al.
Publicado: (2023)

Large-Scale Drug Screen Identifies FDA-Approved Drugs for Repurposing in Sickle-Cell Disease
por: Cannon, Matthew, et al.
Publicado: (2020)

Repurposing existing drugs: identification of irreversible IMPDH inhibitors by high-throughput screening
por: Sarwono, Albertus Eka Yudistira, et al.
Publicado: (2018)

Bv8 Blockade Sensitizes Anti-PD1 Therapy Resistant Tumors
por: Benguigui, Madeleine, et al.
Publicado: (2022)

Host JDP2 expression in the bone marrow contributes to metastatic spread
por: Barbarov, Yelena, et al.
Publicado: (2015)

IL-31 induces antitumor immunity in breast carcinoma
por: Kan, Tal, et al.
Publicado: (2020)

Repurposing infectious disease vaccines for intratumoral immunotherapy
por: Melero, Ignacio, et al.
Publicado: (2020)

Evaluation of the published kinase inhibitor set to identify multiple inhibitors of bacterial ATP-dependent mur ligases
por: Hrast, Martina, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_ngcblp0f1l14n92335kobsbdjq